High activation of SARS 3Cl protease inhibitors and development of anti-COVID-19 drugs
- Funded by KAKENHI
- Total publications:0 publications
Grant number: 21K05417
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$32,760Funder
KAKENHIPrincipal Investigator
Yasunao Hattori UnspecifiedResearch Location
JapanLead Research Institution
Kyoto Pharmaceutical UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable